PFIZER INC.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder
Phase 2
Completed
- Conditions
- Overactive Bladder
- Interventions
- First Posted Date
- 2008-09-04
- Last Posted Date
- 2009-12-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 188
- Registration Number
- NCT00746681
- Locations
- π¬π§
Pfizer Investigational Site, Plymouth, United Kingdom
A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects
- First Posted Date
- 2008-09-04
- Last Posted Date
- 2010-01-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 28
- Registration Number
- NCT00747058
- Locations
- π§πͺ
Pfizer Investigational Site, Bruxelles, Belgium
Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease
- First Posted Date
- 2008-09-01
- Last Posted Date
- 2011-11-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 66
- Registration Number
- NCT00744978
- Locations
- π°π·
Pfizer Investigational Site, Suwon, Korea, Republic of
Tanezumab in Osteoarthritis Of The Hip
Phase 3
Completed
- Conditions
- ArthritisOsteoarthritisOsteoarthritis, Hip
- Interventions
- Biological: PlaceboBiological: tanezumab
- First Posted Date
- 2008-09-01
- Last Posted Date
- 2021-02-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 627
- Registration Number
- NCT00744471
- Locations
- πΊπΈ
Providence Clinical Research, Burbank, California, United States
πΊπΈTrinity Clinical Trials, Santa Ana, California, United States
πΊπΈStamford Therapeutics Consortium, Stamford, Connecticut, United States
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
Phase 4
Completed
- Conditions
- Pneumococcal Infections13-valent Pneumococcal VaccinePneumonia, Pneumococcal
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2014-10-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 84496
- Registration Number
- NCT00744263
- Locations
- π³π±
Pfizer Investigational Site, Zwolle, Netherlands
Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.
Phase 3
Completed
- Conditions
- Pneumococcal Disease13-valent Pneumococcal Vaccine
- Interventions
- Biological: 13-valent Pneumococcal Conjugate Vaccine
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2012-03-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 373
- Registration Number
- NCT00743652
- Locations
- πΊπΈ
Pfizer Investigational Site, Upper Kalskag, Alaska, United States
A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2009-02-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00743847
A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb
Phase 1
Completed
- Conditions
- Osteoarthritis Thumbs
- Interventions
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2018-12-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT00743587
- Locations
- π§πͺ
Pfizer Investigational Site, Bruxelles, Belgium
A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation
Phase 2
Withdrawn
- Conditions
- Smoking Cessation
- Interventions
- First Posted Date
- 2008-08-26
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00741884
Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears
Completed
- Conditions
- Rotator CuffArthroscopic Surgery
- Interventions
- Other: Observational study of the surgical outcome
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2021-02-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 162
- Registration Number
- NCT00739947
- Locations
- πΊπΈ
Cleveland Clinic, Cleveland, Ohio, United States
πΊπΈThe Cleveland Clinic Foundation, Cleveland, Ohio, United States
πΊπΈThe Core Institute, Sun City, Arizona, United States
Β© Copyright 2025. All Rights Reserved by MedPath